IPO Details
Bidding Dates
12 Dec 24 - 16 Dec 24
Price Range ₹
1265 - 1329
Total Equity
₹ 1377.75Cr
Lot Size
11
Exchange Status
BSE,NSE
IPO Doc
Subscription Rate
Non-Institutional Investor
14.55×
Qualified Institutional Buyers
80.64×
Employees
5.20×
Retail Investors
14.55×
Total subscription Rate
52.68×
IPO Timeline
Offer start
12 Dec 2024
Offer end
16 Dec 2024
Allotment
17 Dec 2024
Refund initiation
18 Dec 2024
Demat transfer
18 Dec 2024
Listing
19 Dec 2024
Offer start
12 Dec 2024
Offer end
16 Dec 2024
Allotment
17 Dec 2024
Refund initiation
18 Dec 2024
Demat transfer
18 Dec 2024
Listing
19 Dec 2024
About Company
Founded in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a healthcare technology company specializing in reducing administrative burdens for healthcare providers while improving patient care delivery. The company offers a comprehensive platform with services such as clinical support, virtual medical scribing, and medical documentation management, catering to both outpatient (ambulatory care) and inpatient care needs. Serving over 778 healthcare organizations, including notable clients like Mass General Brigham Inc. and Texas Health Care PLLC, IKS employs 13,528 team members, including 2,612 clinically trained professionals, across the US, Canada, and Australia. Its competitive strengths include a diversified service portfolio, advanced digital and automation technologies, a strong brand reputation among healthcare providers, and a scalable, cost-efficient business model fostering client flexibility and cross-selling opportunities.
Year Founded
05-09-2006
Promotor Details
Berjis Minoo Desai
Promoter Holdings Details
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Percentage | 69.73 | 63.72 |
| Share Capital | 119642752 | 109328542 |
Offer to Public
1,03,66,780.00 Cr
Project Details
- None - Nonecr
Objectives
- The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.
Highlights
- The leadership team comprises experienced professionals, providing strategic direction and deep industry expertise.
- The company maintains long-standing relationships with major healthcare providers and organizations, driving consistent revenue and cross-selling opportunities
- Its scalable business model enables cost-efficient operations, enhancing overall profitability.
- IKS leverages a strong brand reputation and advanced digital technologies to sustain growth and deliver value.
- IKS Health offers services across outpatient and inpatient care, administrative support, and clinical documentation, ensuring diverse revenue streams and reducing reliance on a single source.
Challenges
- Operating in multiple jurisdictions poses regulatory compliance challenges that could affect profitability and operations.
- Healthcare spending is influenced by economic conditions, and a slowdown in global healthcare budgets could impact IKS Health’s revenue.
- The healthcare technology sector is highly competitive, with both established and emerging players vying for market share.
- The IPO is structured as an Offer for Sale, with no fresh capital being infused into the company.
- High promoter shareholding may have implications for investor decision-making and future governance.
Financials
| Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
|---|---|---|---|---|---|
| 2021 | 52,432.96 | 810.88 | 3,052.28 | 3,052.28 | 18.1295 |
| 2023 | 8,935.75 | 168.36 | 2,329.69 | 2,329.69 | 13.7242 |
| 2022 | 7,105.28 | 168.07 | 3,704.86 | 3,704.86 | 21.895 |
| 2020 | 38,593.99 | 805.40 | 10,71,68,744.00 | 10,71,68,710.00 | 0.6841 |
| 2024 | 28,520.68 | 169.21 | 2,329.69 | 2,329.69 | 13.7242 |
